Subtype
Thyroid Gland Neoplasm
CI-CAN-00001600Explore in graph →
Non-malignant189 active trials10 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001600Explore in graph →
Clinical trials
891 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07822880 | A Study of Selpercatinib (LY3527723) in Participants With Rearranged During Transfection (RET)-Altered Cancers in India | not yet recruiting | Phase 4 | 30 | Eli Lilly and CompanyINDUSTRY | 1 | Sep 23, 2026 | clinicaltrials |
| NCT07704658 | Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors | recruiting | Phase 4 | 12 | Rigel PharmaceuticalsINDUSTRY | 1 | Aug 10, 2026 | clinicaltrials |
| NCT07600580 |
| The Association Between Bilateral Intermediate Cervical Plexus Block During Total Thyroidectomy and Surgical Stress Response |
| recruiting |
| Phase 4 |
| 48 |
| University Hospital DubravaOTHER |
| 1 |
| Jun 16, 2026 |
| clinicaltrials |
| NCT03573960 | A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer | completed | Phase 4 | 50 | Eisai Pharmaceuticals India Pvt. LtdINDUSTRY | 1 | Mar 6, 2026 | clinicaltrials |
| NCT07354698 | Application of Mitoxantrone Hydrochloride Injection in Transoral Robotic Thyroid Cancer Surgery(MHI) | not yet recruiting | Phase 4 | 114 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT01496313 | To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer | completed | Phase 4 | 81 | SanofiINDUSTRY | 9 | Oct 3, 2025 | clinicaltrials |
| NCT01896479 | A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer(EXAMINER) | active not recruiting | Phase 4 | 247 | ExelixisINDUSTRY | 14 | Sep 2, 2025 | clinicaltrials |
| NCT07010393 | Genotype-Driven Neoadjuvant Therapy for Locally Advanced Thyroid Cancer: A Real-World Cohort Study | not yet recruiting | Phase 4 | 335 | Fujian Medical UniversityOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT06697782 | Aprepitant and Ondansetron Monotherapy or Combination for Postoperative Nausea and Vomiting in Thyroid Cancer | completed | Phase 4 | 600 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT04574947 | Lidocaine And Neuromonitoring in Thyroid Surgery | completed | Phase 4 | 110 | Saint Petersburg State University, RussiaOTHER | 1 | Mar 21, 2024 | clinicaltrials |
| NCT05949424 | OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults(OPTI-DOSE) | unknown | Phase 4 | 30 | University Medical Center GroningenOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT05830500 | Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma | recruiting | Phase 4 | 360 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Jul 25, 2023 | clinicaltrials |
| NCT03065218 | 99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients | terminated | Phase 4 | 4 | Medstar Health Research InstituteOTHER | 1 | Jul 26, 2022 | clinicaltrials |
| NCT05247476 | Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients. | unknown | Phase 4 | 50 | Zhongshan Hospital Xiamen UniversityOTHER | 1 | Feb 18, 2022 | clinicaltrials |
| NCT03469310 | Minimizing Narcotic Analgesics After Endocrine Surgery | completed | Phase 4 | 126 | Minerva A Romero ArenasOTHER | 1 | May 11, 2021 | clinicaltrials |
| NCT02946918 | Levothyroxine Replacement With Liquid Gel Capsules vs Tablets Post-thyroidectomy | terminated | Phase 4 | 14 | University of Texas Southwestern Medical CenterOTHER | 1 | Dec 1, 2020 | clinicaltrials |
| NCT03969108 | Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment | completed | Phase 4 | 10 | University Health Network, TorontoOTHER | 1 | Mar 27, 2020 | clinicaltrials |
| NCT01915485 | Radiolabeled Molecules for Medullary Thyroid Cancer | unknown | Phase 4 | 20 | Instituto Nacional de Cancer, BrazilOTHER_GOV | 1 | Sep 7, 2016 | clinicaltrials |
| NCT00400465 | Is the Routine Pressure Dressing After Thyroidectomy Necessary? | completed | Phase 4 | 116 | Khon Kaen UniversityOTHER | 1 | Apr 1, 2015 | clinicaltrials |
| NCT00604318 | Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer | completed | Phase 4 | 56 | Copenhagen University Hospital at HerlevOTHER | 1 | Jan 10, 2013 | clinicaltrials |
| NCT00902122 | rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors | unknown | Phase 4 | 600 | Shenzhen SiBiono GeneTech Co.,LtdINDUSTRY | 1 | Apr 9, 2012 | clinicaltrials |
| NCT01308320 | Dose-dependent Effect of Fentanyl on Cough Attenuation During Emergence From General Anaesthesia | completed | Phase 4 | 42 | Yonsei UniversityOTHER | 1 | Mar 4, 2011 | clinicaltrials |
| NCT00001730 | Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal. | completed | Phase 4 | 20 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00385983 | Total Thyroidectomy With Harmonic Scalpel® | unknown | Phase 4 | 280 | Brazilian Society of Head and Neck SurgeryOTHER | 1 | Oct 11, 2006 | clinicaltrials |
Data updated 4 days agoSource updated Sep 23, 2026source: clinicaltrials